HIVE logo

HIVE

Profile

Full Name

HIVE Digital Technologies Ltd.

Ticker Symbol

HIVE

Exchange

NASDAQ

Sector

Financial Services

Industry

Capital Markets

Country

Canada

IPO

February 2, 2011

Indexes

Not included

Website

http://hivedigitaltechnologies.com

Employees

20

Key Details

Price

$1.49(+2.05%)

Market cap

$231.55M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$114.47M(+7.66% YoY)

Annual EPS

-$0.57(+80.00% YoY)

PE ratio

-

Next earnings date

Jun 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.49
HIVE price is $1.49

30-Day Relative Volume

0.45
HIVE 30-day relative volume is 0.45

Price Performance

Price Most recent change

+2.05%
HIVE price was up +2.05% on Apr 17, 2025

Price YTD change

-47.72%
HIVE price is down -47.72% since January 1st

Price 1-year change

-42.69%
HIVE price is down -42.69% year-on-year

Price 3-year change

-82.97%
HIVE price is down -82.97% over the past 3 years

Price Range

Price All-time high

$28.75
HIVE price is currently -94.82% below its historical high of $28.75

Price 3-year low

$1.26
HIVE price is currently +18.25% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$231.55M
HIVE market capitalization is $231.55 million

Market cap 3-year change

-67.82%
HIVE market capitalization is down -67.82% over the past 3 years

Market cap All-time high

$1.87B
HIVE market capitalization is currently -87.62% below its historical high of $1.87 billion

Market cap sector rank

35.92%
HIVE market capitalization is higher than 35.92% of companies in Financial Services sector

Shares Outstanding

Shares Outstanding 1-Year Change

+46.49%
HIVE shares outstanding is up +46.49% year-on-year

Shares Outstanding 3-Year Change

+88.96%
HIVE shares outstanding is up +88.96% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.43
HIVE beta is 2.43

200-day SMA

$3.06
HIVE price is currently -51.31% below its 200-day simple moving average

50-day SMA

$1.94
HIVE price is currently -23.01% below its 50-day simple moving average

RSI

42.39
HIVE 14-day relative strength index is 42.39

Volume

0.45
HIVE 30-day relative volume is 0.45

ATR

$0.13
HIVE average true range is $0.13

10-day Historical Volatility

107.51%
HIVE 10-day historical volatility is 107.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$114.47M
HIVE annual revenue is $114.47 million

Revenue Analysts estimate

$115.91M
HIVE annual revenue is currently -1.25% lower than the consensus analysts' forecast

Revenue 1-year change

+7.66%
HIVE annual revenue is up +7.66% year-on-year

Revenue Sector rank

48.1%
HIVE annual revenue is higher than 48.1% of companies in Financial Services sector

EPS

EPS

-$0.57
HIVE annual earnings per share is -$0.57

EPS Analysts estimate

-
HIVE annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+80%
HIVE annual earnings per share is up +80% year-on-year

EPS Sector rank

9.51%
HIVE annual earnings per share is higher than 9.51% of companies in Financial Services sector

Profit

Gross profit

-$25.98M
HIVE annual gross profit is -$25.98 million

Gross margin

-22.70%
HIVE annual gross profit margin is -22.70%

Operating profit

-$53.21M
HIVE annual operating income is -$53.21 million

Operating margin

-46.49%
HIVE annual operating profit margin is -46.49%

Net income

-$51.20M
HIVE annual net profit is -$51.20 million

Net margin

-44.73%
HIVE annual net profit margin is -44.73%

Expenses

Total expenses

$167.68M
HIVE annual total expenses is $167.68 million

Operating expenses

$27.23M
HIVE annual total operating expenses is $27.23 million

Cost of goods sold

$140.44M
HIVE annual cost of goods sold is $140.44 million

Selling, general & administrative expenses

$20.45M
HIVE annual SGA is $20.45 million

Depreciation and amortization

$65.95M
HIVE annual depreciation & amortization is $65.95 million

Interest expense

$3.56M
HIVE annual interest expense is $3.56 million

Income tax

$6.18M
HIVE annual income tax is $6.18 million

EBIT & EBITDA

EBIT

-$41.46M
HIVE annual earnings before interest & taxes is -$41.46 million

EBITDA

$24.48M
HIVE annual EBITDA is $24.48 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$307.58M
HIVE annual total assets is $307.58 million

Non current assets

$122.36M
HIVE annual long term assets is $122.36 million

Current assets

$185.23M
HIVE annual total current assets is $185.23 million

Cash and cash equivalents

$9.68M
HIVE annual cash & cash equivalents is $9.68 million

Accounts receivable

$6.93M
HIVE annual accounts receivable is $6.93 million

Inventory

$161.65M
HIVE annual inventory is $161.65 million

Liabilities

Total liabilities

$47.89M
HIVE annual total liabilities is $47.89 million

Long term liabilities

$20.54M
HIVE annual total long term liabilities is $20.54 million

Current liabilities

$27.35M
HIVE annual total current liabilities is $27.35 million

Accounts payable

$7.47M
HIVE annual accounts payable is $7.47 million

Debt

Total debt

$30.72M
HIVE annual total debt is $30.72 million

Total debt 1-year change

-14.41%
HIVE annual total debt is down -14.41% year-on-year

Long term debt

$18.12M
HIVE annual long term debt is $18.12 million

Short term debt

$12.60M
HIVE annual short term debt is $12.60 million

Equity & Capital

Shareholders equity

$259.69M
HIVE annual stockholders equity is $259.69 million

Book value

$259.69M
HIVE annual book value is $259.69 million

Retained earnings

-$347.87M
HIVE annual retained earnings is -$347.87 million

Working capital

$157.87M
HIVE annual working capital is $157.87 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$13.53M
HIVE annual cash flow from operations is $13.53 million

Cash from operations 1-year change

-69.8%
HIVE annual cash flow from operations is down -69.8% year-on-year

Cash from investing

-$78.36M
HIVE annual cash flow from investing activities is -$78.36 million

Cash from investing 1-year change

-91.66%
HIVE annual cash flow from investing activities is down -91.66% year-on-year

Cash from financing

$70.15M
HIVE annual cash flow from financing activities is $70.15 million

Cash from financing 1-year change

+1612.18%
HIVE annual cash flow from financing activities is up +1612.18% year-on-year

CAPEX

CAPEX

$79.26M
HIVE annual capital expenditures is $79.26 million

CAPEX 1-year change

+85.06%
HIVE annual capital expenditures is up +85.06% year-on-year

Free Cash Flow

Free cash flow

-$65.73M
HIVE annual free cash flow is -$65.73 million

Free cash flow 1-year change

-3465.69%
HIVE annual free cash flow is down -3465.69% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-22.70%
HIVE annual gross profit margin is -22.70%

Operating margin

-46.49%
HIVE annual operating profit margin is -46.49%

Net margin

-44.73%
HIVE annual net profit margin is -44.73%

ROA & ROE

ROA

-20.33%
HIVE annual return on assets is -20.33%

ROE

-25.07%
HIVE annual return on equity is -25.07%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
HIVE price to earnings ratio value is unknown

PE ratio Sector rank

-
HIVE price to earnings ratio is unknown

PB Ratio

PB ratio

0.53
HIVE price to book ratio is 0.53

PB ratio Sector rank

12.64%
HIVE price to book ratio is higher than 12.64% of companies in Financial Services sector

PS Ratio

PS ratio

1.95
HIVE price to sales ratio is 1.95

PS ratio Sector rank

30.37%
HIVE price to sales ratio is higher than 30.37% of companies in Financial Services sector

Enterprise value

Enterprise value

$246.91M
HIVE enterprise value is $246.91 million

Enterprise value Sector rank

35.71%
HIVE enterprise value is higher than 35.71% of companies in Financial Services sector

EV/EBITDA

EV/EBITDA

3.86
HIVE EV/EBITDA is 3.86

EV/EBITDA Sector rank

51.52%
HIVE EV/EBITDA is higher than 51.52% of companies in Financial Services sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.77
HIVE annual current ratio is 6.77

Quick ratio

0.86
HIVE annual quick ratio is 0.86

Leverage

Debt to equity

0.09
HIVE annual debt to equity ratio is 0.09

Interest coverage ratio

-11.66
HIVE annual interest coverage ratio is -11.66

Risk & Stability

Piotroski F-Score

2
HIVE piotroski f-score is 2

Altman Z-Score

1.86
HIVE altman z-score is 1.86

Analyst ratings

Recent major analysts updates

Mar 26, 25 Canaccord Genuity
Buy
Mar 11, 25 Cantor Fitzgerald
Overweight
Mar 7, 25 Rosenblatt
Buy
Feb 13, 25 HC Wainwright & Co.
Buy
Feb 12, 25 Canaccord Genuity
Buy
Feb 6, 25 Canaccord Genuity
Buy
Dec 19, 24 Roth MKM
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 19, 24 Cantor Fitzgerald
Overweight
Nov 14, 24 Northland Capital Markets
Outperform

Institutional Ownership

Similar stocks

BWFG logo
Bankwell Financial (BWFG)
CLBR logo
Colombier Acquisition (CLBR)
TSBK logo
Timberland Bancorp (TSBK)
WSBF logo
Waterstone Financial (WSBF)
KINS logo
Kingstone Companies (KINS)
ONIT logo
Onity (ONIT)
WHF logo
WhiteHorse Finance (WHF)
Chicago Atlantic BDC (LIEN)
FDBC logo
Fidelity D & D Bancorp (FDBC)
  • What is the ticker symbol for HIVE Blockchain Technologies?
  • Does HIVE Blockchain Technologies pay dividends?
  • What sector is HIVE Blockchain Technologies in?
  • What industry is HIVE Blockchain Technologies in?
  • What country is HIVE Blockchain Technologies based in?
  • When did HIVE Blockchain Technologies go public?
  • Is HIVE Blockchain Technologies in the S&P 500?
  • Is HIVE Blockchain Technologies in the NASDAQ 100?
  • Is HIVE Blockchain Technologies in the Dow Jones?
  • When was HIVE Blockchain Technologies's last earnings report?
  • When does HIVE Blockchain Technologies report earnings?
  • Should I buy HIVE Blockchain Technologies stock now?

What is the ticker symbol for HIVE Blockchain Technologies?

The ticker symbol for HIVE Blockchain Technologies is NASDAQ:HIVE

Does HIVE Blockchain Technologies pay dividends?

No, HIVE Blockchain Technologies does not pay dividends

What sector is HIVE Blockchain Technologies in?

HIVE Blockchain Technologies is in the Financial Services sector

What industry is HIVE Blockchain Technologies in?

HIVE Blockchain Technologies is in the Capital Markets industry

What country is HIVE Blockchain Technologies based in?

HIVE Blockchain Technologies is headquartered in Canada

When did HIVE Blockchain Technologies go public?

HIVE Blockchain Technologies's initial public offering (IPO) was on February 2, 2011

Is HIVE Blockchain Technologies in the S&P 500?

No, HIVE Blockchain Technologies is not included in the S&P 500 index

Is HIVE Blockchain Technologies in the NASDAQ 100?

No, HIVE Blockchain Technologies is not included in the NASDAQ 100 index

Is HIVE Blockchain Technologies in the Dow Jones?

No, HIVE Blockchain Technologies is not included in the Dow Jones index

When was HIVE Blockchain Technologies's last earnings report?

HIVE Blockchain Technologies's most recent earnings report was on Feb 11, 2025

When does HIVE Blockchain Technologies report earnings?

The next expected earnings date for HIVE Blockchain Technologies is Jun 24, 2025

Should I buy HIVE Blockchain Technologies stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page